Chat about Tissue Regenix Group accounts information. See how Tissue Regenix Group is performing financially.

Tissue Regenix Group Accounts Summary


Date of Accounts 20242023202220212020
StandardIFRSIFRSIFRSIFRSIFRS
      
 MillionsMillionsMillionsMillionsMillions
Income Statement31-12-202431-12-202331-12-202231-12-202131-12-2020
Revenue28.6526.3224.4819.7516.47
Operating Profit / Loss0.35-0.61-2.01-4.45-12.58
Net Interest-0.91-1.27-0.82-0.69-0.57
Pre Tax Profit-0.56-1.89-2.83-5.14-13.15
Post Tax Profit-0.85-1.88-2.60-4.99-12.46
Profit for the Period-0.68-1.66-2.60-4.99-12.46
Equity Holders of Parent Company-0.71-1.71-2.69-4.79-12.47
Minority Interests0.030.060.10-0.19n/a
      
Continuing EPS     
Earnings per Share (Basic)-1.20 USX-2.67 USX-3.83 USX-7.00 USX-28.00 USX
Earnings per Share (Diluted)-1.20 USX-2.67 USX-3.83 USX-7.00 USX-28.00 USX
Earnings per Share (Adjusted)-1.20 USX-2.67 USX-3.83 USX-7.00 USX-28.00 USX
Continuing and Discontinued EPS     
Earnings per Share (Basic)-0.96 USX-2.43 USX-3.83 USX-7.00 USX-28.00 USX
Earnings per Share (Diluted)-0.96 USX-2.43 USX-3.83 USX-7.00 USX-28.00 USX
Earnings per Share (Adjusted)-0.96 USX-2.43 USX-3.83 USX-7.00 USX-28.00 USX
      
Dividend per Sharen/a USDn/a USDn/a USDn/a USDn/a USD
      
 MillionsMillionsMillionsMillionsMillions
Balance Sheet31-12-202431-12-202331-12-202231-12-202131-12-2020
Non-Current Assets     
Intangible Assets15.7715.1315.0615.0615.30
Property, Plant and Equipment8.319.028.949.107.75
Investmentsn/an/an/an/an/a
Investment Propertiesn/an/an/an/an/a
Other Financial Assetsn/an/an/an/an/a
Other Non-Current Assetsn/an/an/an/an/a
Total Non-Current Assets24.0824.1524.0024.1623.05
      
Current Assets     
Inventories14.0110.3610.889.729.60
Trade and Other Receivables4.573.734.804.103.59
Cash at Bank and in Hand1.874.655.957.7112.97
Current Asset Investmentsn/an/an/an/an/a
Other Current Assets0.820.350.400.531.12
Total Current Assets21.2719.0922.0322.0627.28
      
Other Assetsn/an/an/an/an/a
Total Assets45.3543.2446.0446.2250.33
      
Current Liabilities     
Borrowings0.610.641.130.120.35
Other Current Liabilities5.544.095.514.244.08
Total Current Liabilities6.164.736.644.364.43
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowings9.858.758.477.836.87
Provisions0.280.400.520.640.76
Other Non-Current Liabilitiesn/an/an/an/an/a
Total Non-Current Liabilities10.139.158.998.477.63
      
Net Assets29.0629.3630.4033.3938.27
      
Capital and Reserves     
Share Capital15.9515.9515.9515.9515.95
Share Premium Account134.36134.25134.18134.17134.17
Other Reserves3.613.713.254.654.55
Retained Earnings-124.09-123.76-122.13-120.43-115.64
Shareholders Funds29.8230.1531.2534.3439.03
      
Minority Interests / Other Equity-0.76-0.80-0.85-0.95-0.76
Total Equity29.0629.3630.4033.3938.27
      
 31-12-202431-12-202331-12-202231-12-202131-12-2020
Operating Margin1.22%-2.33%-8.21%-22.53%-76.38%
Return on Capital Employed1.45%-2.56%-7.89%-16.53%-40.64%
Dividend Covern/an/an/an/an/a
Dividend Yieldn/an/an/an/an/a
PE Ration/an/an/an/an/a
PEGn/an/an/an/an/a
Dividend per Share Growthn/a%n/a%n/a%n/a%n/a%
Net Asset Value per Share0.19 USD0.20 USD0.21 USD0.26 USD0.32 USD